Please go to ENTER SURVEY to give us your feedback on Ursula Theuretzbacher‘s talk “Redeveloping Old Antibiotics for Use: European Initiative." Registration is open for the Oct 13 B2DG event with Caleb Bell. Register now at http://goo.gl/Uq6Joe .
Our Next Event
Caleb B. Bell III -
10/13/2015 - 6:00pm
Wilson Sonsini Goodrich & Rosati- 650 Page Mill Road, Palo Alto, CA
Bell Biosystems was founded around a core discovery of a new synthetic biology tool that adds functionality to cells; this platform was identified by the White House through a competitive process as one of the five most “revolutionary life science platform technologies” in 2014. Bell is currently in beta testing of their Magnelle® cell tracking solution for preclinical tracking and control of...